The estimated Net Worth of Earl Webb Henry is at least $717 Tausend dollars as of 15 June 2011. Earl Henry owns over 5,000 units of Repligen stock worth over $717,000 and over the last 17 years Earl sold RGEN stock worth over $0.
Earl has made over 1 trades of the Repligen stock since 2011, according to the Form 4 filled with the SEC. Most recently Earl bought 5,000 units of RGEN stock worth $18,150 on 15 June 2011.
The largest trade Earl's ever made was buying 5,000 units of Repligen stock on 15 June 2011 worth over $18,150. On average, Earl trades about 625 units every 0 days since 2007. As of 15 June 2011 Earl still owns at least 5,000 units of Repligen stock.
You can see the complete history of Earl Henry stock trades at the bottom of the page.
Earl's mailing address filed with the SEC is C/O REPLIGEN CORPORATION, 41 SEYON STREET SUITE 100, BUILDING 1, WALTHAM, MA, 02453.
Over the last 22 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir und Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: